Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lansoprazole versus omeprazole for bleeding gastric ulcer
ChiCTR1800018588Phase 4Not yet recruiting
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lansoprazole in gastric ulcer and upper gastrointestinal bleeding (UGIB) (2 arms), sponsored by Nanfang Hospital, Southern Medical University. Primary endpoint: 72-hour hemostasis rate. Planned start Oct 2018; status: not yet recruiting.
02
Drugs
lansoprazole
03
Conditions
gastric ulcerupper gastrointestinal bleeding (UGIB)
Beyond the preview
Go deeper on ChiCTR1800018588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018588.